.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The "healthy lifespan" space is attracting more dollars. Juvenescence is out...
The FDA's Oncologic Drugs Advisory Committee voted 8 to 1 against whether Genent...
Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has m...
The FDA's Oncologic Drugs Advisory Committee voted 8 to 1 against whether Genent...
The gene editing company CRISPR Therapeutics struck a deal worth $95 million upf...
Senate Democrats grilled HHS Secretary Robert F. Kennedy Jr. on Tuesday over gap...
FDA chief Marty Makary and new CBER Director Vinay Prasad said that future Covid...
Tourmaline Bio's experimental drug for atherosclerotic heart disease reduced mar...
Plus, news about Beckley Psytech, Regenxbio, Blueprint Medicines, VantAI, NovelM...
The Department of Health and Human Services provided the first details for how i...
The Department of Health and Human Services provided the first details for how i...
Calibrate has replaced its CEO and made several other executive changes, Endpoin...
Healthcare is figuring out what AI to use in a crowded market. Optura says it ca...
Telehealth is becoming more comprehensive than a quick online visit. Portlan...
Biotech execs don’t quite know what to make of the new FDA chief. There’s been p...
Pfizer is set to enter the heated VEGF bispecific arena. The New York drug g...